|Association of Community Health Nursing Educators
10200 West 44th Avenue, Suite 304
Wheat Ridge, CO 80033
Office: (720) 881-6044
FAX: (720) 881-6101
Do you want to contribute something to our website?
|Association of Community Health Nursing Educators
10200 West 44th Avenue, Suite 304
Wheat Ridge, CO 80033
Office: (720) 881-6044
FAX: (720) 881-6101
Do you want to contribute something to our website?
Nominations for the 2017 ACHNE Awards are now being accepted. This is a wonderful way to honor ACHNE members who are deserving of special recognition. Nominations due by 5:00 p.m. Eastern on February 28, 2017. Click here for award criteria and the nomination form.
The Committee’s June Survey validates the need to make ACHNE membership more accessible to nursing students. All the 2016 ACHNE committees’ goals include students as our future Community Health Nurses. It was when the members spoke through their participation in the Communication Committee’s survey that the ACHNE Board started to make this goal a reality.
Secure Your 2017 Sponsorship & Exhibit Space Secure your spot to join us in Baltimore, MD for the 2017 ACHNE Annual Institute, taking place June 8-10, 2017 at the Lord Baltimore Hotel! Our momentum continues to build from year to year, so don't miss out in 2017, as it's sure to be another great meeting! Click here for the PDF.
New Forum thread: HP 2020 Webinar on Diabetes Prevention by SSwider on 01/31/2017 at 2:48PM.
Message: Improving Diabetes Screening and Referral to Prevention Programs: A Healthy People 2020 Spotlight on Health Webinar New!
Register Now | February 21, 2017 | 12:30 to 2:00 p.m. ET
Spread the word!
Tell your colleagues and friends about this great learning opportunity. Forward this email or tweet about the webinar.
Join Healthy People 2020 and the Diabetes Advocacy Alliance on Tuesday, February 21 at 12:30 p.m. ET for a Spotlight on Health webinar about diabetes screening and prevention. We’ll discuss:
o The U.S. Preventive Services Task Force recommendation on blood glucose and type 2 diabetes screening
o Provider referral to evidence-based diabetes prevention programs
o Medicare’s focus on diabetes prevention programs
You’ll also hear from a federally qualified health center in Texas that has improved rates of screening and referral for adults with prediabetes who are at risk for diabetes.
Diabetes affects an estimated 30 million people in the United States. Diabetes screening and referral to diabetes prevention programs are proven strategies for preventing or delaying the onset of type 2 diabetes in people at high risk for developing the disease.
This webinar will highlight 2 Healthy People 2020 objectives:
o Reduce the annual number of new cases of diagnosed diabetes in the population.
o Increase prevention behaviors in persons at high risk for diabetes with prediabetes by increasing levels of physical activity, reducing the amount of fat or calories in their diets, and losing weight.
To view the thread go to http://www.achne.org/i4a/bb/
APHA 2017 Annual Meeting & Expo: “Creating the Healthiest Nation: Climate Changes Health”
Submission Deadline: Friday, February 24, 2017
We welcome empirical research or practice-related presentations, using quantitative, qualitative, or mixed methods. Abstracts should be no more than 250 words. Individuals may submit up to two abstracts as first author to the Aging and Public Health Section. Submissions may be for poster, oral, or roundtable session formats; please note the desired format on the abstract form. All presenters must become individual members of APHA and register for the Annual Meeting to give their presentation. Abstracts cannot be published in any journal prior to the APHA Annual Meeting.
Specific areas of interest to Aging and Public Health include but are not limited to:
***** APH will partner with Home Health Care Services Quarterly (HHCSQ), published by Taylor & Francis, to select abstracts for full manuscript submission to the journal in conjunction with presentations at the upcoming 2017 annual research meeting in Atlanta, GA. Papers selected will undergo expedited peer-review by the journal. If accepted, publications will be scheduled to come out following the annual meeting.
New Forum thread: Nurse in Washington Internship (NIWI): The Lois Capps Scholarship by Pam Levin on 01/30/2017 at 11:45AM.
Please see the attached for information on application process for NIWI scholarship. Applications are due February 8, 2017. ACHNE contributed to establishing this scholarship fund.
To view the thread go to http://www.achne.org/i4a/bb/
New Forum thread: Nursing Community: Activities by Pam Levin on 01/30/2017 at 2:25PM.
Message: ACHNE is a member of the Nursing Community, a coalition of 63 national professional nursing organizations. The NC is a policy and advocacy group, who sends letters to Congress, provides testimony and attends Congressional/Administration meetings on behalf of the membership.
Attached is the NC's 2016 Year in Review
During this time of rapid change in Washington, the NC us working to be a strong and nimble voice for nursing. I will post their letters and advocacy events here, on this discussion board therad, as they come up. To view the thread go to http://www.achne.org/i4a/bb/
New Forum thread COCA: Clinician Outreach and Communication Activity from CDC by Pam Levin on 01/29/2017 at 3:07PM.
Message: Dear Clinician Outreach and Communication Activity (COCA) Partner,
We want to inform you about the following CDC Health Alert Network (HAN) Health Advisory that CDC issued January 24, 2017. Please feel free to share this information with your members.
If you have any questions about this or other clinical issues, please e-mail email@example.com
On behalf of the Clinician Outreach and Communication Activity (COCA)
Centers for Disease Control and Prevention (CDC)
Join us on Facebook
This is an official
CDC HEALTH ADVISORY Distributed via the CDC Health Alert Network January 24, 2017, 14:00 ET (2:00 PM ET) CDCHAN-00400
Investigation of Seoul Virus Outbreak Associated with Home-based, Rat-breeding Facilities in Wisconsin and Illinois
CDC and health officials from Wisconsin and Illinois are conducting an investigation of Seoul virus infections among pet rats and persons exposed to rats at rat-breeding facilities in Wisconsin and Illinois. Seoul virus is a member of the hantavirus group of rodent-borne viruses. Trace-back and trace-out investigations of possibly infected rodents have identified distribution chains in other states that may require additional investigations. People who become infected with this virus often exhibit relatively mild or no symptoms, but some will develop a form of hemorrhagic fever with renal syndrome (HFRS) with death in approximately 1–2% of HFRS cases. Although serologic studies have indicated the presence of Seoul virus in wild rats in the United States, this is the first known outbreak associated with pet rats in the United States.
As part of the outbreak investigation, CDC and Illinois and Wisconsin health officials are conducting trace-back and trace-out investigations to determine where rodents from confirmed-positive facilities may have been distributed.
CDC currently recommends testing of all persons who report recent or current illness after (1) handling rats from a facility with Seoul virus infection that was confirmed by laboratory testing (either rat or human), or (2) handling rats from a facility that sold rats to a facility with Seoul virus infection. Testing is also offered to persons without illness but (1) who are reporting exposure to rats from a facility with Seoul virus infection that was confirmed by laboratory testing, or (2) who are reporting exposure to rats from a facility that sold rats to a facility with Seoul virus infection but where no illness has been reported.
In general, CDC recommends consideration of hantavirus testing in all persons with symptoms of Seoul virus infection and rat contact, even if the rat was not associated with a facility where a confirmed infection in a rat or human was reported.
In the United States, hantavirus infections in people are notifiable conditions. Healthcare providers who suspect hantavirus infection in a patient should contact their state or local health department.
During early December 2016, a home-based rat breeder in Wisconsin developed an acute febrile illness. During late December 2016, CDC tested a blood specimen from the patient and confirmed that the infection was caused by Seoul virus, a member of the hantavirus family of rodent-borne viruses. A family member who worked with rodents also tested positive for Seoul virus. Both people have recovered. A follow-up investigation of rat breeders who supplied the initial patient’s rats revealed six additional human cases of Seoul virus infections occurring at two Illinois rat-breeding facilities. Of the eight confirmed cases in Wisconsin and Illinois, two were hospitalized. Rats at these facilities have also tested positive for Seoul virus.
Human and animal health officials are working together to trace-back from where infected rodents may have come, and trace-out where potentially infected rodents may have been distributed, and make sure infected rats are not distributed further. Persons at risk of Seoul virus infection due to exposure to infected rats are also being identified. To date, state health officials in Alabama, Arkansas, Colorado, Illinois, Indiana, Louisiana, Michigan, Minnesota, South Carolina, Tennessee, Utah, and Wisconsin have been notified that their residents may have infected rats.
Seoul virus is transmitted from rats to people. People who become infected with this virus often exhibit relatively mild or no symptoms, but some develop HFRS (https://www.cdc.gov/
People can become infected after exposure to aerosolized urine, droppings, or saliva of infected rodents or after exposure to dust from their nests or bedding. Transmission may also occur from rat bites or when contaminated materials are directly introduced into broken skin or onto mucous membranes. The incubation period for humans ranges from 1 to 8 weeks; however, most individuals develop symptoms 1 to 2 weeks after exposure. Seoul virus is not spread from human to human. Infected rats do not become sick but can shed virus for many months.
Seoul virus infection in humans is confirmed by testing for Seoul virus IgM and IgG antibodies or by detection of viral RNA. IgM is commonly detectable within a few days after symptom onset and is detectable for approximately 2 to 3 months. IgG can usually be detected within a week after symptom onset and can remain detectable for years. Viral RNA is often detectable in blood from patients with acute disease. In coordination with state health departments, CDC offers testing for patients suspected of having Seoul virus infection.
There is no specific treatment for Seoul virus infection. Individuals with acute disease should have blood values monitored with laboratory testing, including complete blood count, basic metabolic profile, liver enzymes, and urinalysis. Supportive therapy is a mainstay of care. Care includes careful management of the patient’s hydration, renal function, and electrolyte levels; care also includes maintenance of correct oxygen and blood pressure levels and appropriate treatment of any secondary infections. Dialysis may be required to correct severe fluid overload. Intravenous ribavirin is an investigational drug that can be available on an emergency use basis for severe disease (http://www.fda.gov/Drugs/
1. CDC currently recommends laboratory testing for all persons who report recent or current illness after (1) handling rats from a facility with Seoul virus infection that was confirmed by laboratory testing (either rat or human), or (2) handling rats from a facility that sold rats to a facility with Seoul virus infection. Testing is also offered to persons with exposure to rats from a facility with Seoul virus infection that was confirmed by laboratory testing, or to persons with exposure to rats from a facility that sold rats to a facility with Seoul virus infection but where no illness was reported. All testing should be coordinated with the healthcare provider’s local or state health department.
2. Persons with potentially infected rats should not sell, trade, or release their rats. They should contact their state health department with any questions. Healthcare providers should emphasize the importance of safe animal practices with their patients (https://www.cdc.gov/
3. Health care providers may also consider laboratory testing of patients with symptoms suggestive of Seoul virus infection and a history of rat contact, regardless of whether there is known interaction with rats or rat facilities with laboratory confirmed Seoul virus infections.
4. As with all human hantavirus infections, Seoul virus infection is a notifiable disease. Healthcare providers who suspect Seoul virus infection in a patient should report it to their local health department.
5. For laboratory testing inquiries, healthcare providers should contact their state or local health department. Prior approval is required by the state health department.
For More Information:
CDC Seoul virus FAQs: https://www.cdc.gov/
CDC healthy pets website: https://www.cdc.gov/
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Posted Feb 1 Delete Mar 15, 2017
New Forum thread: Community Guide Resources for PHN Faculty and Graduate Students by SSwider on 01/23/2017 at 11:49AM.
Message: The Community Guide has released new resources to help public health practitioners, researchers, and funders understand what insufficient evidence means and how it can be used. Check out the Insufficient Evidence (IE) Findings User Guides to learn how IE findings can benefit your work.
Why are the User Guides important?
• Although the number of insufficient evidence findings is decreasing over time, they still make up around 40% of all Task Force findings and are the most misunderstood. User feedback indicates that an intervention strategy with an IE finding is 1) assumed by funders to not work, 2) understood correctly but ignored by funders who prefer awardees use what is known to be effective in public health, or 3) misunderstood by researchers who are uncertain of what evidence is lacking or how they can contribute to filling evidence gaps.
• Insufficient Evidence Findings User Guides can help public health practitioners, researchers, and funders interpret and use IE findings.
What makes the Insufficient Evidence Findings User Guides credible?
Implementation scientists who specialize in helping people use evidence-based findings, practitioners, and representatives from the following groups collaborated to develop the user guides:
• Task Force Members
• Task Force Liaisons
• Community Guide Branch Staff
What do the User Guides include?
User Guides include the following sections:
• Understanding the Evidence
• Making Decisions Based on the Evidence
• Using IE Findings: An Example from the Field
What’s important to consider when using Insufficient Evidence findings?
An IE finding does not mean that the intervention approach does not work. Rather, it means that more research is needed. The Task Force issues IE findings when there are too few studies, inconsistent evidence, or studies with methodological limitations. Public health practitioners, researchers and funders should understand:
• How an IE finding can inform research and evaluation to fill evidence gaps in a particular topic area.
• How to use IE findings to draft funding opportunities that help fill evidence gaps in a particular area.
What materials are available to help share this information with others?
• News Story - Use this ready-to-go story for newsletters and websites.
• Share the story on Twitter, Facebook, LinkedIn, and Google+ by clicking the share link on the webpage.
• Tweets – retweets and sample messages
• The Community Preventive Service Task Force is now on Twitter @CPSTF. Follow us and retweet messages about the IE User Guides.
If you have any question about the IE User Guides or need assistance with dissemination and implementation please reach out to us at firstname.lastname@example.org. We’re here to help.
Posted Feb 1, 2017 delete Mar 1, 2017
New Forum thread: Connecting Public Health and Food Sector Collaborators: Reducing Sodium through Food Service Guidelines and Nutrition St by SSwider on 01/26/2017 at 1:57PM.
Message: Connecting Public Health and Food Sector Collaborators: Reducing Sodium through Food Service Guidelines and Nutrition Standards
Thursday, February 9
11:00 AM to 12:30 PM Pacific
2:00 PM to 3:30 PM Eastern
More than 75% of the sodium Americans consume comes from processed and restaurant foods—not the salt shaker. Reducing sodium intake requires increased availability of lower sodium packaged and restaurant foods. The government, industry, community groups, and consumers must work together to reduce sodium content in the food supply. This Web Forum will focus on tools, strategies, and promising practices for adopting and implementing food service guidelines and/or nutrition standards to reduce sodium in food service settings.
Web Forum presenters will:
• Showcase the newly released toolkit, “Partnering with Food Service to Reduce Sodium: A Toolkit for Public Health Practitioners.”
• Highlight strategies used to reduce sodium in New Hampshire schools, licensed child care programs, congregate meal sites and one hospital, including successes, challenges, and lessons learned.
About This Web Forum Series
A high sodium diet raises blood pressure, and high blood pressure is a major cause of heart disease and stroke. By reducing sodium, the food industry can have influence over the health of Americans.
To advance sodium reduction efforts and disseminate promising practices, the Centers for Disease Control and Prevention (CDC) and the National Network of Public Health Institutes (NNPHI) launched the Web Forum series, Connecting Public Health and Food Sector Collaborators, hosted by Dialogue4Health. This series features representatives from the food sector who share best practices, success stories and subject matter expertise for public health audiences working with the food industry to reduce sodium. Web Forums also include presentations from public health practitioners who share lessons learned and real-life examples from their work with food industry partners to create change in a variety of food service settings.
See recordings of previous series, Connecting Public Health and Food Service Providers and Connecting Public Health and the Food Industry at www.Dialogue4Health.org.
Partnering with Food Service to Reduce Sodium: A Toolkit for Public Health Practitioners provides public health practitioners with a list of strategies, tools, and resources to build new and/or enhance existing partnerships with food service providers to reduce sodium in foods prepared, served, and sold. NNPHI collaborated with Health Resources in Action and the CDC to develop this free toolkit.
Is the 'RSVP Today!' link not working? Copy and paste the following text into your browser:
Deadline: January 31, 2017
The Association for Prevention Teaching and Research (APTR) and the Centers for Disease Control and Prevention (CDC) announce the availability of funds to develop problem-based case studies aimed at deepening health professions students’ understanding of the value of public health–health care collaboration. Through the 6|18 Initiative, CDC is partnering with health care purchasers, payers, and providers to improve health and control health care costs. CDC provides these partners with rigorous evidence about six high-burden health conditions and associated interventions to inform their decisions to have the greatest health and cost impact. This initiative offers proven interventions that prevent chronic and infectious diseases by increasing their coverage, access, utilization and quality. In particular, CDC is targeting six common and costly health conditions – tobacco use, high blood pressure, healthcare-associated infections, asthma, unintended pregnancies, and diabetes – with 18 proven specific interventions that form the starting point of discussions with purchasers, payers, and providers. It aligns these evidence-based preventive practices with emerging value-based payment and delivery models. For more information and resources, please go to www.aptrweb.org/link.asp?e=
The case study should deepen students’ understanding of three population health concepts in particular:
1. Identify how socioeconomic, environmental, cultural, and other population-level determinants of health are fueling the growth of high-burden health conditions.
2. How to use population health improvement strategies (e.g., systems and policy advocacy, program or policy development) to operationalize interventions on a health systems level.
3. How to use community-engagement strategies to improve the health of communities, contribute to the reduction of health disparities, and promote the sustainability of a system-level intervention.
Each case study will include a facilitator guide for instructors, discussion questions, and a quiz or other form of student assessment. The case study should be applicable to a variety of students across the health professions, and will be promoted by the 11 health professions education associations that comprise the APTR Healthy People Curriculum Task Force.
UMass Dartmouth has openings for many faculty positions - Professor, Associate, and Assistant Professors as well as clinical track professors. Please look at our website for a full description of each position. I would appreciate it if you could forward to anyone who you think might be interested.
Dear Colleagues, I wanted to share information about a new RFA from the EPA to investigate life-long environmental factors influencing health outcomes in later stage of life, called “Total Environment”. Public nonprofit institutions/organizations (includes public institutions of higher education and hospitals) and private nonprofit institutions/organizations (includes private institutions of higher education and hospitals) located in the U.S., state and local governments, Federally Recognized Indian Tribal Governments, and U.S. territories or possessions are eligible to apply. The deadline for applications is approaching quickly-- March 2, 2017. https://www.epa.gov/research-
Catalog of Federal Domestic Assistance (CFDA) Number: 66.509
Solicitation Opening Date: December 2, 2016
Solicitation Closing Date: March 2, 2017, 11:59:59 pm Eastern Time
The U.S. Environmental Protection Agency (EPA), through its Science to Achieve Results (STAR) program, seeks applications for research on how pollution affects human health in the context of the total environment – built, natural, and social environments interacting together with inherent characteristics and interactions. Proposed research should develop and test innovative models or impact assessment approaches to examine causal relationships of chemical pollutants and health effects with modifying interactions among the variables representing all of the major stressors and factors involved in a person’s life. Proposals that integrate a diverse field of disciplines (social science, economics, epidemiology, engineering, environmental science, biology, statistics, toxicology, chemistry, etc.) to address the complexity of the total environment research problem are highly recommended.
This solicitation provides the opportunity for the submission of applications for projects that may involve human subjects research. Human subjects research supported by the EPA is governed by EPA Regulation 40 CFR Part 26 (Protection of Human Subjects). This includes the Common Rule at subpart A and prohibitions and additional protections for pregnant women and fetuses, nursing women, and children at subparts B, C, and D. Research meeting the regulatory definition of intentional exposure research found in subpart B is prohibited by that subpart in pregnant women, nursing women, and children. Research meeting the regulatory definition of observational research found in subparts C and D is subject to the additional protections found in those subparts for pregnant women and fetuses (subpart C) and children (subpart D). All applications must include a Human Subjects Research Statement (HSRS, as described in Section IV.C.5.c of this solicitation), and if the project involves human subjects research, it will be subject to an additional level of review prior to funding decisions being made as described in Sections V.C and V.D of this solicitation.
Guidance and training for investigators conducting EPA-funded research involving human subjects may be obtained here:
Basic Information about Human Subjects Research
Basic EPA Policy for Protection of Subjects in Human Research Conducted or Supported by EPA
In addition to regular awards, this solicitation includes the opportunity for early career awards. The purpose of the early career award is to fund research projects smaller in scope and budget by early career PIs. Please see Section III of this Request for Applications (RFA) for details on the early career eligibility criteria.
Anticipated Type of Award: Grant or Cooperative Agreement
Estimated Number of Awards: 5 regular and 5 early-career awards
Anticipated Funding Amount: Approximately $7 million total for all awards
Potential Funding per Award: Up to a total of $800,000 for regular awards and $600,000 for early career awards, including direct and indirect costs, with a maximum duration of four years.
Cost-sharing is not required. Proposals with budgets exceeding the total award limits will not be considered.
Public nonprofit institutions/organizations (includes public institutions of higher education and hospitals) and private nonprofit institutions/organizations (includes private institutions of higher education and hospitals) located in the U.S., state and local governments, Federally Recognized Indian Tribal Governments, and U.S. territories or possessions are eligible to apply. Special eligibility criteria apply to the early career award portion of this RFA. See full announcement for more details.
· Burden/economic aspects of eye disease/vision loss on society
· Best practices to integrate vision screening/follow up care to system care access
· Vision program effectiveness/evaluation
All research grants need to promote the core mission of Prevent Blindness – preventing blindness and preserving sight. Basic laboratory science research will not be supported under this program. Only applications with investigators and projects based in the United States or Canada will be accepted. Please note preference will be given in 2017 to public health research that relates to AMD and/or glaucoma.
The deadline for the fourteenth annual Joanne Angle Investigator Award is March 6, 2017 at 12pm Eastern. Grants are for a one-year period, up to $25,000, reviewed by a panel of scientists, and commence on July 1, 2017.For more information, visit: http://www.
The National Cancer Institute (NCI) recently announced two companion Funding Opportunity Announcements on reducing overscreening for cancer among older adults. We would like to share the announcements with your list servs.
The purpose of these announcements is to promote research on interventions, based in healthcare settings, designed to reduce overscreening for breast, cervical, or colorectal cancers among average-risk older adults. Overscreening older adults may be driven by factors at the individual, healthcare team, healthcare system and community organization levels. Research supported by this FOA should propose to intervene at two or more levels, and should measure outcomes at two or more levels, while accounting for interactions that occur between levels. Research supported by this FOA should enhance knowledge and consequences of overscreening to improve the health, independence, and quality of life of older adults.
Funding Opportunity Number
Advisory Council Review
Earliest Project Start Date
Reducing Overscreening for Breast, Cervical, and Colorectal Cancers among Older Adults (R21)
Aug or Oct January
Sept or Dec
Reducing Overscreening for Breast, Cervical, and Colorectal Cancers among Older Adults (R01)
Aug or Oct January
Sept or Dec
Mark your calendars! The 2017 Omaha System International Conference: A Key to Practice, Documentation, and Information Management will be held in Eagan, Minnesota. More details are on www.omahasystem.org/